triazoles has been researched along with pyrimidine in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.55) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (9.09) | 29.6817 |
2010's | 26 (59.09) | 24.3611 |
2020's | 12 (27.27) | 2.80 |
Authors | Studies |
---|---|
Fotsch, C; St Jean, DJ | 1 |
Entrala, E; Fernandez-Ramos, C; Luque, F; Navarro, J; Rosales, MJ; Salas, MC; Sánchez-Moreno, M | 1 |
Baraldi, PG; Borean, PA; Cacciari, B; Da Ros, T; Fruttarolo, F; Pastorin, G; Spalluto, G; Tabrizi, MA; Varanin, K | 1 |
MAKISUMI, Y | 1 |
MAKISUMI, Y; TORI, K; WATANABE, H | 1 |
Intine, RV; Maraia, RJ; Schwartz, EI | 1 |
Borea, PA; Catarzi, D; Colotta, V; Filacchioni, G; Lenzi, O; Morizzo, E; Moro, S; Paoletta, S; Poli, D; Varani, K; Varano, F; Vincenzi, F | 1 |
Elchinger, PH; Faugeras, PA; Lucas, R; Zerrouki, R | 1 |
Deflorian, F; Gao, ZG; Jacobson, KA; Kumar, TS; Shinkre, BA; Trenkle, WC | 1 |
Andersen, NK; Døssing, H; Jensen, F; Nielsen, P; Vester, B | 1 |
Huang, LH; Lai, YW; Liu, HM; Lu, YZ; Song, CJ; Wang, YG; Xie, ZY; Zheng, YF | 1 |
Aghazadeh Tabrizi, M; Baraldi, PG; Baraldi, S; Borea, PA; Moorman, AR; Preti, D; Romagnoli, R; Saponaro, G; Varani, K | 1 |
Fandzloch, M; Popławska, B; Sitkowski, J; Łakomska, I | 1 |
Gupta, M; Kaur, P; Kumar, M; Sharma, M; Singh, D | 1 |
Atwal, K; Blanar, M; Caringal, Y; Conder, ML; Finlay, HJ; Harper, T; Hsueh, MM; Jiang, J; Kover, A; Levesque, P; Lloyd, J; Wexler, R; Xing, D | 1 |
Kumar, N; Kumari, N; Luthra, PM; Mishra, CB; Mongre, R; Prakash, A | 1 |
Espinoza-Vázquez, A; González-Olvera, R; Negrón-Silva, GE; Palomar-Pardavé, ME; Romero-Romo, MA; Santillan, R | 1 |
Dong, Q; Fan, J; Feng, J; Gong, A; Liu, Z; Luan, T; Qu, J; Sun, P; Tu, W; Xu, G; Yang, F; Yuan, J; Zhang, H; Zhang, L | 1 |
Kimura, I; Nishigori, K; Ono, M; Onoe, S; Saji, H; Sampei, S; Temma, T | 1 |
Ganesh Kumar, C; Malla Reddy, G; Nagender, P; Naresh Kumar, R; Narsaiah, B; Poornachandra, Y | 1 |
Pathak, AK; Pathak, V; Reynolds, RC | 1 |
Abbas, SE; Abdel-Aziz, HA; Abou-Seri, SM; Eladwy, RA; Fares, M; Youssef, MM | 1 |
Nagesh, N; Raju, G; Reddy, ChR; Reddy, MD; Srinivas, R | 1 |
Hu, B; Liu, HM; Liu, Y; Ma, LY; Pang, LP; Shao, KP; Wang, B; Xue, DQ; Zhang, BL; Zhang, E; Zhang, M | 1 |
David, L; Elster, L; Jensen, T; Klewe, IV; Loechel, F; Nielsen, SM; Poda, SB; Volbracht, C; Watson, SP | 1 |
Appalanaidu, K; Bhadra, MP; Dadmal, TL; Kishore, KS; Kumbhare, RM; Pushpa Valli, SN; Ramaiah, MJ; Rao, YK; Tiwari, SK | 1 |
De Clercq, E; Fang, Z; Huang, B; Kang, D; Liu, H; Liu, X; Pannecouque, C; Zhan, P; Zhang, L | 1 |
Liu, HM; Ma, LY; Pang, LP; Shao, KP; Wang, B; Wang, SQ; Xue, DQ; Zhang, M; Zheng, YC | 1 |
Baumann, M; Baxendale, IR; Rodriguez Garcia, AM | 1 |
Chaudhary, AS; Chen, W; Cui, J; Dai, C; Damera, K; Hsieh, YH; Jin, J; Tai, PC; Wang, B; Zhang, H | 1 |
Ahmad, F; Hassan, MI; Idrees, D; Kumari, S; Mishra, CB; Prakash, A; Tiwari, M | 1 |
Chen, ZS; Guo, Q; Liu, GY; Liu, HM; Liu, Y; Ma, LY; Pang, LP; Wang, B; Zhang, XH; Zhang, XY; Zhao, B; Zhao, YD | 1 |
Chen, XG; Guo, SX; He, SJ; Li, L; Liu, SW; Nandakumar, KS; Tang, XD; Wan, YH; Wu, WY; Wu, XY; Yao, XG; Zou, M | 1 |
Chen, XH; Li, ZH; Liu, GZ; Ma, JL; Qin, TT; Ren, WH; Zhang, XH; Zhang, ZQ; Zhao, TQ | 1 |
Fandzloch, M; Gubernator, J; Jaromin, A; Lewińska, A; Sitkowski, J; Wiśniewska, J; Wojtczak, A; Zaremba-Czogalla, M; Łakomska, I | 1 |
Liu, HM; Ma, XB; Wang, S; Xu, YC; Yu, B; Yuan, XH | 1 |
Hewlett, K; Hughes, SH; Pauly, GT; Schneider, JP; Smith, SJ | 1 |
Bissaro, M; Bortolozzi, R; Cozza, G; Federico, S; Grieco, I; Mariotto, E; Martinez, A; Moro, S; Perez, C; Perez, DI; Redenti, S; Spalluto, G; Tiz, DB; Viola, G | 1 |
Hoda, N; Manzoor, S; Petreni, A; Raza, MK; Supuran, CT | 1 |
Duan, Y; Wang, Y | 1 |
Abd El-Mageed, MMA; Eissa, AAM; Farag, AE; Osman, EEA | 1 |
Jakubowski, M; Jarzęcki, AA; Kaszuba, A; Sitkowski, J; Wojtczak, A; Łakomska, I | 1 |
Anh, HH; Giang, NTK; Hai, DS; Hanh, NT; Huyen, LT; Thanh, ND; Toan, VN; Van, HTK | 1 |
Algieri, V; Costanzo, P; De Nino, A; Fiorani, G; Jiménez-Osés, G; Jiritano, A; Maiuolo, L; Olivito, F; Peccati, F; Tallarida, MA | 1 |
2 review(s) available for triazoles and pyrimidine
Article | Year |
---|---|
Mitigating heterocycle metabolism in drug discovery.
Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats | 2012 |
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?
Topics: Animals; Humans; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyrimidines; Receptors, Purinergic P1; Triazoles | 2002 |
42 other study(ies) available for triazoles and pyrimidine
Article | Year |
---|---|
Biochemical and ultrastructural alterations caused by newly synthesized 1,2,4-triazole[1,5a]pyrimidine derivatives against Phytomonas staheli (Trypanosomatidae).
Topics: Animals; Antiparasitic Agents; DNA; In Vitro Techniques; Magnetic Resonance Spectroscopy; Models, Biological; Organelles; Protein Biosynthesis; Proteins; Pyrimidines; RNA; Triazoles; Trypanosomatina | 2000 |
STUDIES ON AZAINDOLIZINE COMPOUNDS. XV. THE ALLYL REARRANGEMENT OF 5-METHYL-7-ALLYLOXY-S-TRIAZOLO(1,5-A)PYRIMIDINE.
Topics: Chemistry, Pharmaceutical; Pyrimidines; Research; Triazoles | 1963 |
STUDIES ON AZAINDOLIZINE COMPOUNDS. XVIII. PROTON MAGNETIC RESONANCE SPECTRA OF S-TRIAZOLO-(1,5-A)PYRIMIDINE AND ITS DERIVATIVES.
Topics: Chemistry, Pharmaceutical; Magnetic Resonance Spectroscopy; Protons; Pyrimidines; Research; Spectrum Analysis; Triazoles | 1964 |
CK2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5'-terminal oligopyrimidine mRNA metabolism.
Topics: Alanine; Apoptosis; Autoantigens; Casein Kinase II; Cell Line; Humans; Mutation; Phosphorylation; Phosphoserine; Polyribosomes; Protein Processing, Post-Translational; Pyrimidines; Ribonucleoproteins; Ribosomal Proteins; RNA, Messenger; Serine; SS-B Antigen; Triazoles | 2004 |
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.
Topics: Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Amino Acid Sequence; Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Protein Binding; Pyrazoles; Pyrimidines; Pyrimidinones; Receptor, Adenosine A2A; Receptor, Adenosine A3; Substrate Specificity; Triazines; Triazoles | 2009 |
Pyrimidine-purine and pyrimidine heterodinucleosides synthesis containing a triazole linkage.
Topics: Catalysis; Copper; Cyclization; Nucleic Acid Conformation; Oligonucleotides; Purines; Pyrimidines; Triazoles | 2010 |
Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists.
Topics: Adenosine A2 Receptor Antagonists; Binding Sites; Cell Line; Computer Simulation; Contrast Media; Fluorine Radioisotopes; Humans; Positron-Emission Tomography; Protein Structure, Tertiary; Pyrazoles; Pyrimidines; Receptor, Adenosine A2A; Triazoles | 2010 |
Duplex and triplex formation of mixed pyrimidine oligonucleotides with stacking of phenyl-triazole moieties in the major groove.
Topics: Base Sequence; Circular Dichroism; Deoxycytidine; Deoxyuridine; DNA, Complementary; Models, Molecular; Molecular Structure; Nucleic Acid Conformation; Nucleosides; Nucleotides; Oligonucleotides; Pyrimidines; RNA, Complementary; Triazoles | 2011 |
Synthesis of novel D-ring fused 7'-aryl-androstano[17,16-d][1,2,4] triazolo[1,5-a]pyrimidines.
Topics: Aldehydes; Androstanols; Dehydroepiandrosterone; Heterocyclic Compounds; Models, Chemical; Molecular Structure; Pyrimidines; Steroids; Triazoles | 2012 |
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
Topics: Humans; Protein Binding; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Structure-Activity Relationship; Triazoles | 2012 |
Platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo [1,5-a]pyrimidines: spectroscopical characterization and cytotoxic activity in vitro.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Female; Humans; Magnetic Resonance Spectroscopy; Organoplatinum Compounds; Pyrimidines; Triazoles | 2012 |
Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
Topics: Animals; Binding Sites; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Hypoglycemic Agents; Male; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrimidines; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 2012 |
Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists.
Topics: Animals; Cell Line; Imidazoles; Isomerism; Kv1.5 Potassium Channel; Mice; Potassium Channel Blockers; Potassium Channels; Protein Binding; Pyrazoles; Pyrimidines; Structure-Activity Relationship; Triazoles | 2013 |
8-(Furan-2-yl)-3-phenethylthiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione as novel, selective and potent adenosine A(2A) receptor antagonist.
Topics: Adenosine A2 Receptor Antagonists; Animals; Catalepsy; Cyclic AMP; HEK293 Cells; Heterocyclic Compounds, 3-Ring; Humans; Male; Mice; Molecular Docking Simulation; Motor Activity; Pyrimidines; Radioligand Assay; Receptor, Adenosine A2A; Rotarod Performance Test; Triazoles | 2014 |
Multicomponent click synthesis of new 1,2,3-triazole derivatives of pyrimidine nucleobases: promising acidic corrosion inhibitors for steel.
Topics: Click Chemistry; Corrosion; Electric Impedance; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pyrimidines; Steel; Triazoles | 2013 |
Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists.
Topics: Administration, Oral; Animals; Cyclopentanes; Dogs; Dose-Response Relationship, Drug; Humans; Molecular Structure; Platelet Aggregation; Platelet-Rich Plasma; Purinergic P2Y Receptor Antagonists; Pyrimidines; Rats; Receptors, Purinergic P2Y12; Structure-Activity Relationship; Triazoles | 2014 |
Development of a radioiodinated triazolopyrimidine probe for nuclear medical imaging of fatty acid binding protein 4.
Topics: Adipose Tissue; Animals; Autoradiography; Carboxylic Acids; Cell Line; Cell Line, Tumor; Fatty Acid-Binding Proteins; Immunohistochemistry; Iodine Radioisotopes; Male; Mice; Mice, Inbred BALB C; Protein Binding; Pyrimidines; Pyrimidinones; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triazoles | 2014 |
Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Biofilms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Pyridines; Pyrimidines; Structure-Activity Relationship; Triazoles | 2014 |
Solution-phase parallel synthesis of acyclic nucleoside libraries of purine, pyrimidine, and triazole acetamides.
Topics: Acetamides; Molecular Structure; Nucleosides; Purines; Pyrimidines; Small Molecule Libraries; Solutions; Triazoles | 2014 |
Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Pyrimidines; Triazoles | 2014 |
Studies on non-covalent interaction of coumarin attached pyrimidine and 1-methyl indole 1,2,3 triazole analogues with intermolecular telomeric G-quadruplex DNA using ESI-MS and spectroscopy.
Topics: Coumarins; DNA; G-Quadruplexes; Humans; Indoles; Pyrimidines; Spectrometry, Mass, Electrospray Ionization; Spectrum Analysis; Telomere; Triazoles | 2014 |
Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles | 2014 |
The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function.
Topics: Animals; Drug Inverse Agonism; Mice; Pyrimidines; Receptors, G-Protein-Coupled; Triazoles | 2014 |
Synthesis and anticancer evaluation of novel triazole linked N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine derivatives as inhibitors of cell survival proteins and inducers of apoptosis in MCF-7 breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP1A1; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; MCF-7 Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Pyrimidines; Structure-Activity Relationship; Thiazoles; Triazoles | 2015 |
Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors.
Topics: Anti-HIV Agents; Cell Line; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; HIV-1; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triazoles | 2015 |
Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Humans; Neoplasms; Pyrimidines; Structure-Activity Relationship; Triazoles; Urea | 2015 |
Flow synthesis of ethyl isocyanoacetate enabling the telescoped synthesis of 1,2,4-triazoles and pyrrolo-[1,2-c]pyrimidines.
Topics: Acetates; Chemistry Techniques, Synthetic; Models, Molecular; Molecular Conformation; Nitriles; Phosgene; Pyrimidines; Triazoles | 2015 |
Design, Synthesis and Evaluation of Triazole-Pyrimidine Analogues as SecA Inhibitors.
Topics: Adenosine Triphosphatases; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Membrane Transport Proteins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; SEC Translocation Channels; SecA Proteins; Structure-Activity Relationship; Triazoles | 2016 |
Design and synthesis of a novel class of carbonic anhydrase-IX inhibitor 1-(3-(phenyl/4-fluorophenyl)-7-imino-3H-[1,2,3]triazolo[4,5d]pyrimidin 6(7H)yl)urea.
Topics: Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Drug Design; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Pyrimidines; Spectrometry, Fluorescence; Triazoles; Urea | 2016 |
Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2018 |
[1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.
Topics: Animals; Antiviral Agents; Cell Proliferation; Cells, Cultured; Cricetinae; Dengue; Dengue Virus; Inflammation; Microbial Sensitivity Tests; Molecular Docking Simulation; Pyrimidines; Recombinant Proteins; RNA-Dependent RNA Polymerase; Surface Plasmon Resonance; Triazoles; Viral Nonstructural Proteins | 2020 |
[1,2,3]Triazolo[4,5-d]pyrimidine derivatives incorporating (thio)urea moiety as a novel scaffold for LSD1 inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Molecular Docking Simulation; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles | 2020 |
Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.
Topics: Antineoplastic Agents; Capsules; Cell Line, Tumor; Coordination Complexes; Humans; Hydrophobic and Hydrophilic Interactions; Liposomes; Melanoma; Nanostructures; Pyrimidines; Ruthenium; Triazoles | 2020 |
Discovery of new [1,2,4] Triazolo[1,5-a]Pyrimidine derivatives that Kill gastric cancer cells via the mitochondria pathway.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Pyrimidines; Reactive Oxygen Species; Stomach Neoplasms; Triazoles | 2020 |
Structure-based non-nucleoside inhibitor design: Developing inhibitors that are effective against resistant mutants.
Topics: Anti-HIV Agents; Binding Sites; Drug Design; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Dynamics Simulation; Mutation; Pyridones; Pyrimidines; Rilpivirine; Triazoles | 2021 |
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.
Topics: Binding Sites; Blood-Brain Barrier; Casein Kinase Idelta; Cell Line; Cell Survival; Drug Design; Humans; Kinetics; Molecular Docking Simulation; Protein Kinase Inhibitors; Pyrimidines; Static Electricity; Structure-Activity Relationship; Thermodynamics; Triazines; Triazoles | 2021 |
Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: Design, synthesis, computational and enzyme inhibition studies.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Drug Design; Humans; Isoenzymes; Models, Molecular; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Sulfonamides; Triazoles | 2021 |
P2Y14R for inflammation therapy: is it a promising target?
Topics: Anti-Inflammatory Agents; Benzofurans; Benzoic Acid; Biomarkers; Drug Evaluation, Preclinical; Humans; Inflammation; Naphthalenes; Purinergic P2 Receptor Antagonists; Pyrimidines; Receptors, Purinergic P2; Structure-Activity Relationship; Triazoles | 2021 |
Design and synthesis of novel furan, furo[2,3-d]pyrimidine and furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as potential VEGFR-2 inhibitors.
Topics: Cell Cycle Checkpoints; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Furans; Human Umbilical Vein Endothelial Cells; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship; Triazoles; Vascular Endothelial Growth Factor Receptor-2 | 2021 |
Factors Affecting the Stability of Platinum(II) Complexes with 1,2,4-Triazolo[1,5-
Topics: Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Oxides; Platinum; Pyrimidines; Sulfoxides; Thiophenes; Triazoles | 2022 |
Design, Synthesis, α-Amylase/α-Glucosidase Inhibition Assay, Induced Fit Docking Study of New Hybrid Compounds Containing 4H-Pyrano[2,3-d]pyrimidine, 1H-1,2,3-Triazole and D-Glucose Components.
Topics: alpha-Amylases; alpha-Glucosidases; Amylases; Glucose; Glucosidases; Glycoside Hydrolase Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles | 2022 |
Regioselective Synthesis and Molecular Docking Studies of 1,5-Disubstituted 1,2,3-Triazole Derivatives of Pyrimidine Nucleobases.
Topics: Azides; COVID-19; Humans; Molecular Docking Simulation; SARS-CoV-2; Triazoles | 2022 |